Acquired by Amazon in Mar 2023
ONEM - 1Life Healthcare, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
San Francisco,
United States
Type: Equity
ONEM price evolution
ONEM
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $143.76 | $188.53 | $243.78 | $345.77 |
| Short term investments | $127.7 | $162.87 | $141.06 | $111.67 |
| Net receivables | $189.28 | $153.16 | $142.29 | $103.5 |
| Inventory | $7.77 | $6.57 | $6.02 | $6.07 |
| Total current assets | $518.8 | $560.33 | $584.13 | $613.03 |
| Long term investments | $47.44 | $48.3 | ||
| Property, plant & equipment | $489.32 | $477.78 | $465.73 | $450.01 |
| Goodwill & intangible assets | $1480.56 | $1491.5 | $1486.29 | $1499.62 |
| Total noncurrent assets | $1983.97 | $1980.59 | $2011.9 | $2014.01 |
| Total investments | $127.7 | $162.87 | $188.5 | $159.97 |
| Total assets | $2502.77 | $2540.92 | $2596.03 | $2627.03 |
| Current liabilities | ||||
| Accounts payable | $22.84 | $17.05 | $15.84 | $18.73 |
| Deferred revenue | $78.5 | $83.42 | $91.7 | $77.25 |
| Short long term debt | $38.99 | $36.47 | $33.32 | $31.15 |
| Total current liabilities | $247.68 | $216.48 | $221.1 | $202.11 |
| Long term debt | $606.29 | $602.38 | $593.52 | $579.49 |
| Total noncurrent liabilities | $698.6 | $699.96 | $699.09 | $696.34 |
| Total debt | $645.29 | $638.84 | $626.84 | $610.64 |
| Total liabilities | $946.27 | $916.44 | $920.18 | $898.45 |
| Shareholders' equity | ||||
| Retained earnings | -$914.9 | -$802.87 | -$709.06 | -$618.2 |
| Other shareholder equity | -$1.34 | -$1.53 | -$1.23 | -$0.19 |
| Total shareholder equity | $1556.5 | $1624.48 | $1675.85 | $1728.58 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $345.77 | $114.89 | $29.31 | $36.69 |
| Short term investments | $111.67 | $570.02 | $119.15 | |
| Net receivables | $103.5 | $67.89 | $30.45 | $15.97 |
| Inventory | $6.07 | $7.11 | $3.19 | $3.85 |
| Total current assets | $613.03 | $774.7 | $196.89 | $256.34 |
| Long term investments | $48.3 | |||
| Property, plant & equipment | $450.01 | $264.88 | $198.76 | $42.75 |
| Goodwill & intangible assets | $1499.62 | $21.3 | $21.32 | |
| Total noncurrent assets | $2014.01 | $296.29 | $230.26 | $69.98 |
| Total investments | $159.97 | $570.02 | $119.15 | |
| Total assets | $2627.03 | $1070.99 | $427.15 | $326.32 |
| Current liabilities | ||||
| Accounts payable | $18.73 | $12.65 | $13.85 | $5.32 |
| Deferred revenue | $77.25 | $43.59 | $23.88 | $21.76 |
| Short long term debt | $31.15 | $17.42 | $15.86 | |
| Total current liabilities | $202.11 | $117.43 | $80.33 | $53.54 |
| Long term debt | $579.49 | $394.85 | $120.5 | $3.2 |
| Total noncurrent liabilities | $696.34 | $405.09 | $128.36 | $421.02 |
| Total debt | $610.64 | $412.26 | $136.35 | |
| Total liabilities | $898.45 | $522.51 | $208.69 | $474.56 |
| Shareholders' equity | ||||
| Retained earnings | -$618.2 | -$369.79 | -$281.07 | -$228.45 |
| Other shareholder equity | -$0.19 | $0.01 | $0.04 | $4.16 |
| Total shareholder equity | $1728.58 | $548.48 | -$187.07 | |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $261.37 | $255.84 | $254.1 | $230.21 |
| Cost of revenue | $212.87 | $215.85 | $206.34 | $192.64 |
| Gross Profit | $48.5 | $39.99 | $47.76 | $37.57 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $142.46 | $115.61 | $119.5 | $112.87 |
| Total operating expenses | $165.78 | $137.4 | $140.39 | $133.42 |
| Operating income | -$117.28 | -$97.41 | -$92.63 | -$95.85 |
| Income from continuing operations | ||||
| EBIT | -$116.65 | -$97.04 | -$92.47 | -$95.77 |
| Income tax expense | -$4.54 | -$6.92 | -$6.73 | -$3.94 |
| Interest expense | -$0.08 | $3.68 | $5.12 | $3.61 |
| Net income | ||||
| Net income | -$112.04 | -$93.81 | -$90.86 | -$95.43 |
| Income (for common shares) | -$112.04 | -$93.81 | -$90.86 | -$95.43 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $623.32 | $380.22 | $276.26 | $212.68 |
| Cost of revenue | $435.18 | $234.96 | $167.62 | |
| Gross Profit | $188.13 | $145.26 | $108.64 | $76.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $385.12 | $194.25 | $148.49 | |
| Total operating expenses | $431.62 | $216.62 | $162.75 | $121.72 |
| Operating income | -$243.48 | -$71.36 | -$54.11 | -$45.05 |
| Income from continuing operations | ||||
| EBIT | -$242.69 | -$75.41 | -$51.99 | |
| Income tax expense | -$1.8 | -$0.12 | $0.09 | $0.03 |
| Interest expense | $13.76 | $13.43 | $0.47 | $0.8 |
| Net income | ||||
| Net income | -$254.64 | -$88.72 | -$52.55 | -$44.41 |
| Income (for common shares) | -$254.64 | -$88.72 | -$52.55 | |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$112.04 | -$93.81 | -$90.86 | -$95.43 |
| Operating activities | ||||
| Depreciation | $32.2 | $29.89 | $28.84 | $28.3 |
| Business acquisitions & disposals | $0.09 | -$10.45 | ||
| Stock-based compensation | $38.5 | $32.34 | $36.92 | $31.1 |
| Total cash flows from operations | -$64.8 | -$59.79 | -$55.08 | -$73.23 |
| Investing activities | ||||
| Capital expenditures | -$20.61 | -$14.96 | -$19.23 | -$19.72 |
| Investments | $35 | $25 | -$29.91 | -$40.3 |
| Total cash flows from investing | $14.48 | -$0.41 | -$49.13 | -$60.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.37 | $4.87 | $2.23 | $5.43 |
| Net borrowings | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Total cash flows from financing | $5.86 | $4.86 | $2.22 | $5.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$44.47 | -$55.35 | -$101.99 | -$127.84 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 30 Jan 2019 |
|---|---|---|---|---|
| Net income | -$254.64 | -$88.72 | -$52.55 | -$45.5 |
| Operating activities | ||||
| Depreciation | $68.56 | $36.03 | $24.5 | |
| Business acquisitions & disposals | -$23.26 | -$0.81 | ||
| Stock-based compensation | $112.3 | $35.09 | $14.88 | |
| Total cash flows from operations | -$88.57 | -$4.38 | -$31.67 | -$18.41 |
| Investing activities | ||||
| Capital expenditures | -$63.62 | -$63.71 | -$54.41 | |
| Investments | $408.68 | -$449.96 | $78.13 | |
| Total cash flows from investing | $291.8 | -$514.47 | $23.72 | -$176.76 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $27.86 | $322.27 | $3.04 | |
| Net borrowings | -$0.05 | $303.52 | -$4.42 | |
| Total cash flows from financing | $27.81 | $604.53 | -$1.38 | $216.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $231.05 | $85.68 | -$9.33 | $21.43 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 196.23M |
| Revenue | $1.00B |
|---|---|
| EBITDA | -$282.70M |
| EBIT | -$401.93M |
| Net Income | -$392.14M |
| Revenue Q/Q | 72.71% |
| Revenue Y/Y | 94.51% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 7.94 |
| Cash/Share | 0.73 |
| EPS | -$2.00 |
|---|---|
| ROA | -15.28% |
| ROE | -23.82% |
| Debt/Equity | 0.52 |
|---|---|
| Net debt/EBITDA | -2.84 |
| Current ratio | 2.09 |
| Quick ratio | 2.06 |